Red Orbit (Free subscription) | 07/23/2008
Premier Purchasing Partners, LP, today announced new agreements for invasive hemodynamic monitoring products and accessories have been awarded to Edwards Lifesciences LLC of Irvine, Calif.; Hospira Worldwide Inc. of Lake Forest, Ill.; and Pulsion Medical Inc.
Seeking Alpha (Free subscription) | 07/23/2008
Edwards Lifesciences Corp. (EW) Q2 FY08 Earnings Call Complete Story ยป
SignalBlog (Free subscription) | 07/22/2008
Edwards Lifesciences Corp., which makes heart valves and other cardiovascular products, said Tuesday its second-quarter profit rose 14 percent on sales increases from a range of products including heart valves and hospital systems. The company earned $39.7 million, or 67 cents per share, compared with profit of $34.9 million, or 57 cents per share, during the [...]
PR News Wire (Free subscription) | 07/15/2008
IRVINE, Calif., July 15 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), a world leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended June 30, 2008 after the market closes on Tuesday, July 22, 2008 and will host a conference call at 5:00 p.m. ET that day to discuss its results. To participate...
Market Watch (Free subscription) | 07/11/2008
NEW YORK (MarketWatch) -- Edwards Lifesciences Corp. said Friday its board has authorized the repurchase of up to $250 million of the company's outstanding common shares. Edwards recently completed a $250 million share repurchase program that its board approved in September 2007. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more...
PR News Wire (Free subscription) | 07/11/2008
IRVINE, Calif., July 11 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), a world leader in products and technologies to treat advanced cardiovascular disease, announced today that its board of directors has authorized a new share repurchase program to acquire up to $250 million of the company's outstanding common shares. Edwards recently completed a $250 million share repurchase...
Arik's blog (Free subscription) | 07/05/2008
Learn about the World Cardiovascular Catheters and Systems Market MarketWatch - 21 hours ago ... AVI BioPharma Regains Full Control on Resten-NG Antisense Therapy II-43 Boston Scientific Acquires Precision Vascular Systems II-43 Edwards Lifesciences ...
Medical News Today (Free subscription) | 06/20/2008
On Nov. 26, 2007, doctors at the Cedars-Sinai Heart Institute performed the first "transcatheter" minimally invasive replacement of an aortic heart valve in the western United States, using the SAPIEN transcatheter aortic heart valve developed by Edwards Lifesciences Corp.
PR News Wire (Free subscription) | 06/17/2008
IRVINE, Calif., June 17 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the 18th Annual Wachovia Nantucket Equity Conference at the White Elephant Hotel in Nantucket, Massachusetts on Tuesday, June 24, 2008. Thomas M. Abate, Edwards Lifesciences' corporate vice...
PR News Wire (Free subscription) | 06/04/2008
IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Goldman Sachs 29th Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel Hotel in Dana Point, California on Wednesday, June 11, 2008. Thomas M. Abate, Edwards Lifesciences'...
PR News Wire (Free subscription) | 05/30/2008
IRVINE, Calif., May 30 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), a world leader in products and technologies to treat advanced cardiovascular disease, said today that it has received additional questions from the U.S. Food and Drug Administration (FDA) regarding the company's submission for premarket approval of LifeStent products for a superficial femoral artery (SFA) indication....
Business Times Asiaone (Free subscription) | 05/22/2008
HEART valve maker Edwards Lifesciences yesterday opened a US$20 million plant in Singapore that will bring the company significant benefits not only in terms of costs but also in greater access to Asian patients.
PR News Wire (Free subscription) | 05/22/2008
SINGAPORE, May 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: ), the world leader in the science of heart valves, today announced the opening of its new heart valve manufacturing facility in Changi North Crescent, Singapore. The state-of-the-art facility produces Edwards' world-leading Carpentier-Edwards PERIMOUNT tissue heart valve replacements, and also serves as the headquarters...
Seeking Alpha (Free subscription) | 05/08/2008
The Correct Call submits: Edwards LifeSciences (EW) is an interesting small/mid cap play in this market. First off, the company provides products and technologies designed to treat cardiovascular diseases. It focuses primarily on heart valve disease, peripheral vascular disease, and critical care technologies. On April 22, the company raised its full-year sales and earnings guidance, citing strength...
Business Week (Free subscription) | 04/23/2008
Egbert believes that a strong quarter marked by better than expected revenue, deferred revenue and billings, as well as a ramp in enterprise license agreements (ELAs) should somewhat ease fears that the looming entry by Microsoft may be profoundly impacting customer purchase decisions. While VMW is not completely immune to macroeconomic conditions, she thinks its themes of costs savings and improved...
